KoBioLabs, Inc (KOSDAQ:348150)
South Korea · Delayed Price · Currency is KRW 3,140.00
+60.00 (1.95%)
At close: Jul 21, 2026
KoBioLabs Market Cap
KoBioLabs has a market cap or net worth of 60.98 billion as of July 21, 2026. Its market cap has decreased by -42.91% in one year.
Market Cap
60.98B
Enterprise Value
47.29B
Revenue
71.21B
Ranking
n/a
PE Ratio
n/a
Stock Price
3,140.00
ChartMarket Cap Chart
Since November 18, 2020, KoBioLabs's market cap has decreased from 493.16B to 60.98B, a decrease of -87.64%. That is a compound annual growth rate of -30.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 60.98B | -45.20% |
| Dec 30, 2025 | 111.27B | 7.15% |
| Dec 30, 2024 | 103.84B | -35.34% |
| Dec 28, 2023 | 160.60B | -16.02% |
| Dec 29, 2022 | 191.23B | -42.95% |
| Dec 30, 2021 | 335.17B | -50.18% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 18, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SunBio,Inc. | 75.11B |
| BIO-FD&C | 72.78B |
| CTCBIO | 70.05B |
| QuadMedicine | 68.89B |
| AriBioLab | 67.82B |
| EyeGene | 64.46B |
| PanGen Biotech | 61.69B |
| ABION | 60.82B |